Linked Data API

Show Search Form

Search Results

1002558
star this property registered interest false more like this
star this property date less than 2018-11-06more like thismore than 2018-11-06
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the ability of the NHS long-term plan to (a) tackle the evolving challenges of cancer and (b) ensure that people are able to access personalised and tailored support after they have finished cancer treatment itself. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 188796 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-14more like thisremove minimum value filter
star this property answer text <p>The NHS Long Term Plan provides an excellent opportunity to look at how cancer and other services can be further improved over the next decade. The plan is currently in development and will be published later in the year.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-11-14T11:29:49.547Zmore like thismore than 2018-11-14T11:29:49.547Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1017502
star this property registered interest false more like this
star this property date less than 2018-11-30more like thismore than 2018-11-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what proportion of (a) leukaemia, (b) non-Hodgkin lymphoma, (c) Hodgkin lymphoma and (d) myeloma cases were diagnosed at each cancer stage in each of the last five years. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 197620 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-10more like thismore than 2018-12-10
star this property answer text <p>This information is not held centrally.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-12-10T15:38:39.683Zmore like thismore than 2018-12-10T15:38:39.683Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1039028
star this property registered interest false more like this
star this property date remove maximum value filtermore like thismore than 2019-01-10
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Asparaginase more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether Erwinase will be available for the treatment for children with acute lymphoblastic leukaemia between January 2019 and March 2019; and if he will make a statement. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 207238 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-18more like thismore than 2019-01-18
star this property answer text <p>Erwinase is produced by Porton Biopharma Ltd (PBL) and is licensed and distributed by Jazz Pharmaceuticals under a global licencing agreement.</p><p> </p><p>Due to increased demand for Erwinase and because PBL are manufacturing at capacity, until increases in capacity are brought into beneficial use there will be occasional stock-outs.</p><p> </p><p>The product is currently in stock in the United Kingdom. The Department has been informed, it is likely there will be a short stock-out in early February 2019 and then a further batch is planned to be released to Jazz Pharmaceuticals, who are responsible for the packaging/distribution and allocation of worldwide product supply, anticipated to reach the UK market by mid-February 2019 which should last until the end of March 2019.</p><p> </p><p>The Department and Public Health England (PHE) are in close contact with, and have been kept informed by the PBL management of short periods of interrupted supply. PBL have and will be implementing a series of initiatives to increase capacity and better supply the market in both the short and long term. PBL are fully aware of the consequences that the unavailability of Erwinase has on patients and are absolutely committed to working with all involved to resolve any issues and be able to supply this critical medicine.</p><p> </p><p>The Department and PHE will continue to monitor the situation closely.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-18T12:18:00.113Zmore like thismore than 2019-01-18T12:18:00.113Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this